Literature DB >> 34166506

Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.

Pyoeng Gyun Choe1, Chang Kyung Kang1, Kye-Hyung Kim2, Jongyoun Yi3, Eu Suk Kim1, San Won Park1, Nam Joong Kim1, Wan Beom Park1, Myoung-Don Oh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34166506     DOI： 10.1093/infdis/jiab339

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection.

Authors:  Costanza Di Chiara; Anna Cantarutti; Paola Costenaro; Daniele Donà; Francesco Bonfante; Chiara Cosma; Martina Ferrarese; Sandra Cozzani; Maria Raffaella Petrara; Francesco Carmona; Cecilia Liberati; Paolo Palma; Giovanni Di Salvo; Anita De Rossi; Mario Plebani; Andrea Padoan; Carlo Giaquinto
Journal:  JAMA Netw Open       Date:  2022-07-01

2.  Long-term evolution of humoral immune response after SARS-CoV-2 infection.

Authors:  Elisa Teyssou; Karen Zafilaza; Sophie Sayon; Stéphane Marot; Margot Dropy; Cathia Soulie; Basma Abdi; Florence Tubach; Pierre Hausfater; Anne-Geneviève Marcelin; David Boutolleau
Journal:  Clin Microbiol Infect       Date:  2022-03-17       Impact factor: 13.310

3.  Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity.

Authors:  Chang Kyung Kang; Minji Kim; Jisu Hong; Gwanghun Kim; Soojin Lee; Euijin Chang; Pyoeng Gyun Choe; Nam Joong Kim; Ik Soo Kim; Jun-Young Seo; Daesub Song; Dong-Sup Lee; Hyun Mu Shin; Yong-Woo Kim; Chang-Han Lee; Wan Beom Park; Hang-Rae Kim; Myoung-Don Oh
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 8.786

4.  Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic.

Authors:  Pyoeng Gyun Choe; Yuri Kim; Euijin Chang; Chang Kyung Kang; Nam Joong Kim; Nam-Hyuk Cho; Wan Beom Park; Myoung-Don Oh
Journal:  J Korean Med Sci       Date:  2022-02-28       Impact factor: 2.153

5.  Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection.

Authors:  Chang Kyung Kang; Hyun Mu Shin; Pyoeng Gyun Choe; Jiyoung Park; Jisu Hong; Jung Seon Seo; Yung Hie Lee; Euijin Chang; Nam Joong Kim; Minji Kim; Yong-Woo Kim; Hang-Rae Kim; Chang-Han Lee; Jun-Young Seo; Wan Beom Park; Myoung-Don Oh
Journal:  BMC Med       Date:  2022-05-04       Impact factor: 11.150

Review 6.  Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses.

Authors:  Yajie Lin; Jiajie Zhu; Zongming Liu; Chaonan Li; Yikai Guo; Ying Wang; Keda Chen
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

7.  Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes.

Authors:  Rhiane Moody; Sabrina Sonda; Fay H Johnston; Kylie J Smith; Nicola Stephens; Michelle McPherson; Katie L Flanagan; Magdalena Plebanski
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

8.  Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 Pandemic.

Authors:  Stephen M Friedman; Jieliang Li; Pauline Thomas; Manisha Gurumurthy; Richard Siderits; Anna Nepomich; Edward Lifshitz
Journal:  J Community Health       Date:  2022-10-05

9.  Factors influencing the immune response over 15 months after SARS-CoV-2 infection: A longitudinal population-wide study in the Faroe Islands.

Authors:  Maria Skaalum Petersen; Laura Pérez-Alós; Jose Juan A Armenteros; Cecilie B Hansen; Jógvan Páll Fjallsbak; Sólrun Larsen; Jóhanna L Hansen; Ida Jarlhelt; Marnar F Kristiansen; Fríða Við Streym; Bjarni Á Steig; Debes H Christiansen; Lars F Møller; Marin Strøm; Guðrið Andorsdóttir; Shahin Gaini; Pál Weihe; Peter Garred
Journal:  J Intern Med       Date:  2022-08-23       Impact factor: 13.068

10.  Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection.

Authors:  Jan Van Elslande; Matthijs Oyaert; Natalie Lorent; Yannick Vande Weygaerde; Gijs Van Pottelbergh; Lode Godderis; Marc Van Ranst; Emmanuel André; Elizaveta Padalko; Katrien Lagrou; Stien Vandendriessche; Pieter Vermeersch
Journal:  Diagn Microbiol Infect Dis       Date:  2022-02-12       Impact factor: 2.803
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.